210 Diagnostic Solutions
UEI: Y88CDSXG3NT1
• CAGE: 943E4
Overview
Awardee Type
Parent
Federal Capability Statement
We are a startup biotechnology company commercializing a novel antibody test with offices at The EDGE in Tuscaloosa, Alabama. We are comprised of four founding members, each with a background in STEM and each pursuing their MBA. 210 Diagnostic Solutions plans to acquire laboratory space to initiate research and development of a product prototype upon achieving initial funding goals. This lab space will likely be acquired through a business accelerator/incubator program within Alabama (Innovation Depot in Birmingham, Hudson Alpha in Huntsville, etc.).
Keywords
Diagnostic, antibody, test, biotechnology, luciferase
Headquarters
Tuscaloosa, AL
United States
United States
Federal recipient
210 DIAGNOSTIC SOLUTIONS, LLC
(UEI Y88CDSXG3NT1, CAGE 943E4)
is headquartered in Tuscaloosa AL.
Its primary registered NAICS is 325413 In-Vitro Diagnostic Substance Manufacturing.
The corporation
was founded in June 2021 and
federally registered in
July 2021.
Federal Registration and Certifications
Legal Name
210 DIAGNOSTIC SOLUTIONS, LLC
UEI
Y88CDSXG3NT1
CAGE Code
943E4
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
June 17, 2021
Initial Registration
July 29, 2021
Last Registration
Oct. 27, 2022
Registration Activation
Aug. 4, 2021
Registration Expiration
Oct. 27, 2022
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Limited Liability Company
Limited Liability Company
State of Incorporation
AL
Country of Incorporation
USA
Employees
<500
Disaster Registry
Nationwide
Reported NAICS
Accepts Credit Cards
Yes